These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 31176960)

  • 1. Incidence of skeletal-related events in patients with breast or prostate cancer-induced bone metastasis or multiple myeloma: A 12-year longitudinal nationwide healthcare database study.
    Baek YH; Jeon HL; Oh IS; Yang H; Park J; Shin JY
    Cancer Epidemiol; 2019 Aug; 61():104-110. PubMed ID: 31176960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Payer costs for inpatient treatment of pathologic fracture, surgery to bone, and spinal cord compression among patients with multiple myeloma or bone metastasis secondary to prostate or breast cancer.
    Barlev A; Song X; Ivanov B; Setty V; Chung K
    J Manag Care Pharm; 2010; 16(9):693-702. PubMed ID: 21067255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zoledronic acid and skeletal-related events in patients with bone metastatic cancer or multiple myeloma.
    Jeon HL; Oh IS; Baek YH; Yang H; Park J; Hong S; Shin JY
    J Bone Miner Metab; 2020 Mar; 38(2):254-263. PubMed ID: 31673791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health resource utilization associated with skeletal-related events: results from a retrospective European study.
    Body JJ; Pereira J; Sleeboom H; Maniadakis N; Terpos E; Acklin YP; Finek J; Gunther O; Hechmati G; Mossman T; Costa L; Rogowski W; Nahi H; von Moos R
    Eur J Health Econ; 2016 Jul; 17(6):711-21. PubMed ID: 26253584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural history of skeletal-related events in patients with breast, lung, or prostate cancer and metastases to bone: a 15-year study in two large US health systems.
    Oster G; Lamerato L; Glass AG; Richert-Boe KE; Lopez A; Chung K; Richhariya A; Dodge T; Wolff GG; Balakumaran A; Edelsberg J
    Support Care Cancer; 2013 Dec; 21(12):3279-86. PubMed ID: 23884473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone metastasis and skeletal-related events in patients with solid cancer: A Korean nationwide health insurance database study.
    Hong S; Youk T; Lee SJ; Kim KM; Vajdic CM
    PLoS One; 2020; 15(7):e0234927. PubMed ID: 32678818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of bone metastases and skeletal-related events in breast cancer patients: a population-based cohort study in Denmark.
    Jensen AØ; Jacobsen JB; Nørgaard M; Yong M; Fryzek JP; Sørensen HT
    BMC Cancer; 2011 Jan; 11():29. PubMed ID: 21261987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of skeletal related events in SEER-Medicare: a comparison of claims-based methods.
    Aly A; Onukwugha E; Woods C; Mullins CD; Kwok Y; Qian Y; Arellano J; Balakumaran A; Hussain A
    BMC Med Res Methodol; 2015 Aug; 15():65. PubMed ID: 26286392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone metastasis, skeletal-related events, and mortality in lung cancer patients: a Danish population-based cohort study.
    Cetin K; Christiansen CF; Jacobsen JB; Nørgaard M; Sørensen HT
    Lung Cancer; 2014 Nov; 86(2):247-54. PubMed ID: 25240518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk Factors for Developing Skeletal-Related Events in Breast Cancer Patients With Bone Metastases Undergoing Treatment With Bone-Modifying Agents.
    Tanaka R; Yonemori K; Hirakawa A; Kinoshita F; Takahashi N; Hashimoto J; Kodaira M; Yamamoto H; Yunokawa M; Shimizu C; Fujimoto M; Fujiwara Y; Tamura K
    Oncologist; 2016 Apr; 21(4):508-13. PubMed ID: 26975863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Clinical and Economic Impacts of Skeletal-Related Events Among Medicare Enrollees With Prostate Cancer Metastatic to Bone.
    McDougall JA; Bansal A; Goulart BH; McCune JS; Karnopp A; Fedorenko C; Greenlee S; Valderrama A; Sullivan SD; Ramsey SD
    Oncologist; 2016 Mar; 21(3):320-6. PubMed ID: 26865591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The economic burden of skeletal-related events among elderly men with metastatic prostate cancer.
    Jayasekera J; Onukwugha E; Bikov K; Mullins CD; Seal B; Hussain A
    Pharmacoeconomics; 2014 Feb; 32(2):173-91. PubMed ID: 24435407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skeletal-related events (SREs) in breast cancer patients with bone metastases treated in the nontrial setting.
    Trinkaus M; Simmons C; Myers J; Dranatisaris G; Clemons M
    Support Care Cancer; 2010 Feb; 18(2):197-203. PubMed ID: 19424729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid Use Among Metastatic Prostate Cancer Patients With Skeletal-related Events.
    Yaldo A; Wen L; Ogbonnaya A; Valderrama A; Kish J; Eaddy M; Kreilick C; Tangirala K; Shields K
    Clin Ther; 2016 Aug; 38(8):1880-9. PubMed ID: 27478111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of skeletal related events among elderly prostate cancer patients by site of metastasis at diagnosis.
    Hussain A; Aly A; Daniel Mullins C; Qian Y; Arellano J; Onukwugha E
    Cancer Med; 2016 Nov; 5(11):3300-3309. PubMed ID: 27730756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are Current Survival Prediction Tools Useful When Treating Subsequent Skeletal-related Events From Bone Metastases?
    Pan YT; Lin YP; Yen HK; Yen HH; Huang CC; Hsieh HC; Janssen S; Hu MH; Lin WH; Groot OQ
    Clin Orthop Relat Res; 2024 Sep; 482(9):1710-1721. PubMed ID: 38517402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Approval summary for zoledronic acid for treatment of multiple myeloma and cancer bone metastases.
    Ibrahim A; Scher N; Williams G; Sridhara R; Li N; Chen G; Leighton J; Booth B; Gobburu JV; Rahman A; Hsieh Y; Wood R; Vause D; Pazdur R
    Clin Cancer Res; 2003 Jul; 9(7):2394-9. PubMed ID: 12855610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors predicting skeletal-related events in patients with bone metastatic castration-resistant prostate cancer.
    Klaassen Z; Howard LE; de Hoedt A; Amling CL; Aronson WJ; Cooperberg MR; Kane CJ; Terris MK; Freedland SJ
    Cancer; 2017 May; 123(9):1528-1535. PubMed ID: 28026865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do skeletal-related events predict overall survival in men with metastatic castration-resistant prostate cancer?
    Howard LE; De Hoedt AM; Aronson WJ; Kane CJ; Amling CL; Cooperberg MR; Terris MK; Divers CH; Valderrama A; Freedland SJ
    Prostate Cancer Prostatic Dis; 2016 Dec; 19(4):380-384. PubMed ID: 27377207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for skeletal-related events (SREs) and factors affecting SRE-free survival for nonsmall cell lung cancer patients with bone metastases.
    Ulas A; Bilici A; Durnali A; Tokluoglu S; Akinci S; Silay K; Oksuzoglu B; Alkis N
    Tumour Biol; 2016 Jan; 37(1):1131-40. PubMed ID: 26276360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.